Performance analysis of Impact BioMedical (IBO)
Annual Return
Since Sep 16, 2024, IBO has had an average annual return of -62.01%, underperforming the benchmark SPY, which returned +18.19% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.88% | -65.18% | -45.90% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.97% | -11.16% | +37.87% | +13.31% | -23.53% | -11.55% | -2.16% | -10.88% | |||||
| 2025 | +20.68% | -9.70% | -44.95% | -50.92% | +20.84% | +25.45% | -5.67% | -5.05% | +14.70% | -19.51% | -16.68% | +13.22% | -65.18% |
| 2024 | -25.37% | +12.50% | +29.78% | -50.35% | -45.90% |
Drawdown analysis of Impact BioMedical (IBO)
The maximum drawdown for the IBO was -92.70%, occurring on Jun 20, 2025. This drawdown has not yet recovered.
The current IBO drawdown is -90.93%.
Since Sep 16, 2024 IBO has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 3 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.70% | Mar 21, 2025 | 62 | Jun 20, 2025 | Ongoing | Ongoing | Ongoing |
| -82.56% | Nov 18, 2024 | 81 | Mar 19, 2025 | 2 | Mar 21, 2025 | 83 |
| -53.36% | Sep 16, 2024 | 20 | Oct 14, 2024 | 15 | Nov 4, 2024 | 35 |
| -13.45% | Nov 8, 2024 | 4 | Nov 14, 2024 | 1 | Nov 15, 2024 | 5 |
| -4.44% | Nov 4, 2024 | 2 | Nov 6, 2024 | 1 | Nov 7, 2024 | 3 |